Dr. S. K. Burman launches his mission to make health care products in Calcutta.
With growing popularity of Dabur products, Dr. Burman expands his operations by setting up a manufacturing plant for mass production of formulations.
Dabur enters the specialised area of nature-based Ayurvedic medicines , for which standardised drugs are not available in the market.
The need to develop scientific processes and quality checks for mass production of traditional Ayurvedic medicines leads to establishment of research laboratories.
Dabur expands further with new manufacturing units at Narendrapur and Daburgram. The distribution of Dabur products spreads to Bihar and the North-East.
Dabur becomes a full-fledged company - Dabur India (Dr. S. K. Burman) Pvt. Ltd.
Dabur's operations shift to Delhi. A new manufacturing plant is set up in temporary premises in Faridabad on the outskirts of Delhi.
Commercial production starts in the new Sahibabad factory of Dabur, one of the largest and best equipped production facilities for Ayurvedic medicines. Launch of full-fledged research operations in pioneering areas of health care with establishment of the Dabur Research & Development Centre (DRDC).
Dabur becomes a Public Limited Company. Dabur India Ltd. comes into being after reverse merger with Vidogum Limited.
Beginning a new chapter of strategic partnerships with international businesses, Dabur enters into a joint venture with Agrolimen of Spain. This new venture is to manufacture and market confectionery items in India.
Dabur enters the specialised health care area of cancer treatment with its oncology formulation plant at Baddi in Himachal Pradesh.
Dabur India Ltd. raises its first public issue. Due to market confidence in the Company, shares issued at a high premium are oversubscribed 21 times.
Extending its global partnerships, Dabur enters into a Joint Venture (JV) with Osem of Israel for food and Bongrain of France for Cheese & other dairy products.
For better operation and management, 3 separate divisions are created according to their product mix - Health Care, Products Division, Family Product Division & Dabur Ayurvedic Specialities Limited.
Dabur enters full-scale in the nascent processed foods market with creation of a Foods Division. Project STARS (Strive to Achieve Record Successes) is initiated to give a jump-start to the Company and accelerate its growth performance.
With changing demands of business and to inculcate a spirit of corporate governance, the Burman family inducts professional to manage the company. For the first time in the history of Dabur, a non family professional CEO sits at the helm of the company.
Dabur establishes its market leadership status with a turnover of Rs.1,000 crores. From a small beginning and upholding the values of its founder, Dabur now enters the august league of large corporate businesses.
Dabur India approved the demerger of its pharmaceuticals business from the FMCG business into a separate company as part of plans to provide greater focus to both the businesses.
As part of its inorganic growth strategy, Dabur India acquires Balsara's Hygiene and Home products businesses, a leading provider of Oral Care and Household Care products in the Indian Market, in a INR 143 Crore all cash deal.
Dabur India announces issue of 1:1 bonus share to its shareholders (i.e. one share for every one share held.)
Dabur India crosses the $2 billion mark in market Capitalisation. The company also adopted US GAAP in the line with the commitment to follow Global Best Practices and adopt highest standards of transparency and governance.
Moving forward on the inorganic growth path Dabur India decides to raise upto $200 million from the international market through bonds, FCCBs, GDR, ADR, QIPs or any other securities.
Dabur Foods unveils the new packaging and design for Real on the occasion of 10 years completion of the brand. The new defined modern look depicts the natural goodness of the juice from freshly plucked fruits.
Dabur India announces its foray into the organised retail business through a wholly-owned subsidiary, H&B Stores Limited. Dabur goes on to further invest INR 140 Crores by 2010 to establish its presence in the retail market in India with a chain of stores on the Health & Beauty format.
Dabur India decides to merge its wholly owned subsidiary Dabur Foods Limited with itself to exact synergies and unlock operational efficiencies.
Dabur India acquires Fem Care Pharma, a leading player in the women skin care market. Besides an entry into the high growth skin care market with an established brand named Fem, this transaction also offers Dabur a strong platform to enter newer product categories and markets.
Dabur Red Paste becomes Dabur's 9th billion rupee brand by crossing the billion rupee turnover mark within 5 years of its launch.
Dabur makes its first overseas acquisitions by buying Hobi Kozmetik Group, a leading personal care products company in Turkey, for $69 Million. This is followed in succession by the acquisition of 100% equity in Namaste Laboratories LLC of the US for $100 Million.
Dabur enters professional skin care market with the launch of Oxylife Professional Facial Kit, created exclusively for professional use. The range is further expanded with the launch of facials and a body bleach under the brand Fem.
Dabur India Limited acquires Ajanta Pharma's over-the-counter brand '30-Plus'
Dabur India Ltd. surpasses the billion-dollar turnover mark during the 2011-12 fiscal to end the year on a high note with net sales of INR 5283.17 Crores.
Copyrights Reserved By Dabur.com